162 related articles for article (PubMed ID: 26517331)
1. Clinical and Serologic Response to the 23-valent Polysaccharide Pneumococcal Vaccine in Children and Teens with Recurrent Upper Respiratory Tract Infections and Selective Antibody Deficiency.
Estrada J; Najera M; Pounds N; Catano G; Infante AJ
Pediatr Infect Dis J; 2016 Feb; 35(2):205-8. PubMed ID: 26517331
[TBL] [Abstract][Full Text] [Related]
2. Response to pneumococcal polysaccharide vaccine in children with asthma, and children with recurrent respiratory infections, and healthy children.
Quezada A; Maggi L; Norambuena X; Inostroza J; Quevedo F
Allergol Immunopathol (Madr); 2016; 44(4):376-81. PubMed ID: 27255476
[TBL] [Abstract][Full Text] [Related]
3. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
[TBL] [Abstract][Full Text] [Related]
4. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
Nuorti JP; Whitney CG;
MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
[TBL] [Abstract][Full Text] [Related]
5. Specific antibody deficiency with normal immunoglobulin concentration in children with recurrent respiratory infections.
Quezada A; Norambuena X; Inostroza J; Rodríguez J
Allergol Immunopathol (Madr); 2015; 43(3):292-7. PubMed ID: 25498324
[TBL] [Abstract][Full Text] [Related]
6. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
7. Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies.
Tuerlinckx D; Vermeulen F; Pékus V; de Bilderling G; Glupczynski Y; Collet S; Jamart J; Bodart E; Mascart F
Clin Exp Immunol; 2007 Aug; 149(2):295-302. PubMed ID: 17511778
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immune response to pneumococcal capsular polysaccharides.
Jeurissen A; Boudewijns M; Proesmans M; Ceuppens JL; De Boeck K; Bossuyt X
Acta Clin Belg; 2003; 58(2):106-10. PubMed ID: 12836493
[TBL] [Abstract][Full Text] [Related]
9. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
Hidalgo H; Moore C; Leiva LE; Sorensen RU
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
[TBL] [Abstract][Full Text] [Related]
11. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
Borgers H; Meyts I; De Boeck K; Raes M; Sauer K; Proesmans M; Moens L; Jeurissen A; Flamaing J; Peetermans WE; Verhaegen J; Bossuyt X
Clin Immunol; 2012 Nov; 145(2):136-8. PubMed ID: 23026475
[No Abstract] [Full Text] [Related]
12. Defective pneumococcal antibody response in patients with recurrent respiratory tract infections.
Erman B; Demirtaş D; Bildik HN; Çağdaş-Ayvaz D; Sanal Ö; Tezcan İ
Turk J Pediatr; 2017; 59(5):555-560. PubMed ID: 29745117
[TBL] [Abstract][Full Text] [Related]
13. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy.
Lu CL; Chang SY; Chuang YC; Liu WC; Su CT; Su YC; Chang SF; Hung CC
Vaccine; 2014 Feb; 32(9):1031-5. PubMed ID: 24440112
[TBL] [Abstract][Full Text] [Related]
14. Selective antibody deficiency and its relation to the IgG2 and IgG3 subclass titers in recurrent respiratory infections.
Sherkat R; Shoaei P; Parvaneh N; Babak A; Kassaian N
Iran J Immunol; 2013 Mar; 10(1):55-60. PubMed ID: 23502339
[TBL] [Abstract][Full Text] [Related]
15. Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production.
Cohn JA; Skorpinski E; Cohn JR
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):603-5. PubMed ID: 17165266
[TBL] [Abstract][Full Text] [Related]
16. Selective deficiency in pneumococcal antibody response in children with recurrent infections.
Epstein MM; Gruskay F
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):125-31. PubMed ID: 7648376
[TBL] [Abstract][Full Text] [Related]
17. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
18. Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.
Ruuskanen O; Nurkka A; Helminen M; Viljanen MK; Käyhty H; Kainulainen L
Clin Exp Immunol; 2013 May; 172(2):238-44. PubMed ID: 23574320
[TBL] [Abstract][Full Text] [Related]
19. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices
MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
[TBL] [Abstract][Full Text] [Related]
20. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.
Cordonnier C; Labopin M; Chesnel V; Ribaud P; Camara Rde L; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Bonnet E; Einsele H; Niederwieser D; Apperley J; Ljungman P
Vaccine; 2010 Mar; 28(15):2730-4. PubMed ID: 20117269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
